Abstract:Studies on associations between ataxia telangiectasia-mutated (ATM) polymorphisms and late radiotherapy-induced adverse events vary in clinical settings, and the results are inconsistent.We conducted the first meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to investigate the role of the ATM polymorphism rs1801516 in the development of radiotherapy-induced late fibrosis.We searched PubMed, Embase, Web of Science, and Chinese National Knowledge Infrastructure databases to identify studies that investigated the effect of the ATM polymorphism rs1801516 on radiotherapy-induced late fibrosis before September 8, 2015. Summary odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were used to assess the association between late fibrosis and the rs1801516 polymorphism. Subgroup analyses were conducted to evaluate the influence of clinical features on the genetic association. Tests of interaction were used to compare differences in the effect estimates between subgroups.The overall meta-analysis of 2000 patients from 9 studies showed that the minor allele of the rs1801516 polymorphism was associated with a significantly increased risk of developing late fibrosis (OR = 1.78, 95% CI: 1.07, 2.94), with high between-study heterogeneity (I = 66.6%, P = 0.002). In subgroup analyses, we identified that the incidence of late fibrosis was a major source of heterogeneity across studies. The OR for patients with a high incidence of late fibrosis was 3.19 (95% CI: 1.86, 5.47), in contrast to 1.09 (95% CI: 1.01, 1.17) for those with a low incidence. There was a significant difference in the effect estimates between the 2 subgroups (ratio of OR = 2.94, 95% CI 1.70, 5.08, P = 0.031).This meta-analysis supported previously reported effect of the ATM polymorphism rs1801516 on radiotherapy-induced late fibrosis. This finding encouraged further researches to identify more genetic polymorphisms that were predictive for radiotherapy-induced adverse events. In addition, we showed that the inconsistency of the associations seen in these studies might be related to variations in the incidence of late fibrosis in the patients. This suggested that future studies should consider the incidence of radiotherapy-induced adverse events when investigating radiosensitivity signature genes.

Functional Polymorphism Rs189037 in the Promoter Region of ATM Gene is Associated with Angiographically Characterized Coronary Stenosis

The association of single nucleotide polymorphism rs189037C>T in ATM gene with coronary artery disease in Chinese Han populations: A case control study.

Discovery of a Pathogenic Variant Rs139379666 (p. P2974L) in ATM for Breast Cancer Risk in Chinese Populations

EDNRA Gene rs1878406 Polymorphism is Associated With Susceptibility to Large Artery Atherosclerotic Stroke

Polymorphism rs189037C > T in the promoter region of the ATM gene may associate with reduced risk of T2DM in older adults in China: a case control study

Association Between ATM Rs1801516 Polymorphism and Cancer Susceptibility: a Meta-Analysis Involving 12,879 Cases and 18,054 Controls

A Functional Single Nucleotide Polymorphism in Promoter of ATM is Associated with Longevity.

ATM Polymorphisms Are Associated with Radiosensitivity for Patients with Esophageal Squamous Cell Carcinoma Underwent Preoperative Radiation Therapy

Association between the rs189037 single nucleotide polymorphism in the ATM gene promoter and cognitive impairment.

Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients

Association of the ATM Gene Polymorphisms with Papillary Thyroid Cancer

[Research on Association Between Ataxia Telangiectasia Mutated(ATM)Gene Single Nucleotide Polymorphism Rs189037 C>T and Essential Hypertension].

Association between polymorphism of Ataxia-telangiectasia mutated (rs189307)and the susceptibility of lung cancer:a Me-ta-analysis

ATG 16 L 1 rs 2241880 polymorphism predicts unfavorable clinical outcomes for colorectal cancer patients in the Chinese population

The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis

Single Nucleotide Polymorphism rs1801516 in Ataxia Telangiectasia-Mutated Gene Predicts Late Fibrosis in Cancer Patients After Radiotherapy: A PRISMA-Compliant Systematic Review and Meta-Analysis.

Single Nucleotide Polymorphism in ATM and Non-Small Cell Lung Cancer Susceptibility

A Pleiotropic ATM Variant (rs1800057 C>G) is Associated with Risk of Multiple Cancers

Mutant Single Nucleotide Polymorphism rs189037 in Ataxia-Telangiectasia Mutated Gene Is Significantly Associated With Ventricular Wall Thickness and Human Lifespan

ATM sequence variants associate with susceptibility to non-small cell lung cancer.

Ataxia Telangiectasia-Mutated (atm)polymorphisms and Risk of Lung Cancer in a Chinese Population